CROX

Crocs, Inc. NASDAQ

Consumer Cyclical ·Apparel - Footwear & Accessories ·US · crocs.com

$103.88

Mkt Cap $5.6B

52w Low $73.21 61.8% of range 52w High $122.84

50d MA $90.88 200d MA $87.32

P/E (TTM) -69.2x

EV/EBITDA 6.2x

P/B 4.3x

Debt/Equity 1.2x

ROE -6.3%

P/FCF 7.0x

RSI (14) —

ATR (14) —

Beta 1.54

50d MA $90.88

200d MA $87.32

Avg Volume 1.4M

About

Crocs, Inc., together with its subsidiaries, designs, develops, manufactures, markets, and distributes casual lifestyle footwear and accessories for men, women, and children. It offers various footwear products, including clogs, sandals, slides, flip-flops, boots, flats, wedges, platforms, socks, shoe charms, loafers, sneakers, and slippers under the Crocs brand name. The company sells its product…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 30, 2026	BMO	2.78	2.99	+7.6%	100.14	-3.7%	+1.8%	+3.7%	—	—	—	—	—
Feb 12, 2026	BMO	1.92	2.29	+19.3%	82.73	+16.6%	+19.0%	+17.1%	+20.8%	+18.7%	+16.6%	-4.5%	—
Oct 30, 2025	BMO	2.36	2.92	+23.7%	84.69	+5.1%	-2.5%	-3.5%	-4.2%	-7.1%	-5.3%	+2.3%	—
Aug 7, 2025	BMO	4.01	4.23	+5.5%	105.13	-22.5%	-29.2%	-28.4%	-27.2%	-25.9%	-20.7%	-17.1%	—
May 8, 2025	BMO	2.51	3.00	+19.5%	100.76	+6.5%	+9.8%	+8.9%	+18.0%	+19.4%	+17.4%	+1.5%	—
Feb 13, 2025	BMO	2.27	2.52	+11.0%	88.83	+24.6%	+23.9%	+22.1%	+20.8%	+24.9%	+22.6%	+16.9%	—
Oct 29, 2024	BMO	3.10	3.60	+16.1%	138.05	-17.6%	-19.2%	-21.0%	-21.9%	-23.1%	-23.0%	-23.5%	—
Aug 1, 2024	BMO	3.56	4.01	+12.6%	134.37	-5.8%	-2.6%	-8.2%	-9.9%	-5.7%	-6.1%	+4.1%	—
May 7, 2024	BMO	2.23	3.02	+35.4%	126.63	+5.1%	+7.8%	+6.9%	+10.3%	+13.1%	+12.9%	+17.2%	—
Feb 15, 2024	BMO	2.38	2.58	+8.4%	108.37	+7.6%	+12.2%	+9.8%	+6.7%	+6.8%	+8.2%	+19.9%	—
Nov 2, 2023	BMO	3.10	3.25	+4.8%	87.41	-15.1%	-5.3%	-4.0%	-6.0%	-3.4%	-5.1%	+20.2%	—
Jul 27, 2023	BMO	2.97	3.59	+20.9%	119.80	-7.9%	-14.6%	-9.7%	-9.6%	-10.7%	-12.9%	-19.2%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 1	UBS	Maintains	Neutral → Neutral	—	$101.98	$101.95	-0.0%	+1.9%	—	—	—	—
May 1	Barclays	Maintains	Equal Weight → Equal Weight	—	$101.98	$101.95	-0.0%	+1.9%	—	—	—	—
Apr 21	Needham	Maintains	Buy → Buy	—	$111.19	$111.86	+0.6%	-3.5%	-5.3%	-6.3%	-8.0%	-7.0%
Apr 14	Seaport Global	Upgrade	Neutral → Buy	—	$100.22	$104.21	+4.0%	+1.0%	+2.3%	+2.0%	+5.6%	+10.9%
Feb 13	Goldman Sachs	Maintains	Sell → Sell	—	$98.46	$99.87	+1.4%	-1.6%	+1.5%	-0.3%	-2.0%	+1.6%
Feb 13	Barclays	Maintains	Equal Weight → Equal Weight	—	$98.46	$99.87	+1.4%	-1.6%	+1.5%	-0.3%	-2.0%	+1.6%
Feb 13	Stifel	Maintains	Hold → Hold	—	$98.46	$99.87	+1.4%	-1.6%	+1.5%	-0.3%	-2.0%	+1.6%
Feb 12	Needham	Maintains	Buy → Buy	—	$82.73	$96.50	+16.6%	+19.0%	+17.1%	+20.8%	+18.7%	+16.6%
Jan 22	KeyBanc Capital Markets	Downgrade	Overweight → Sector Weight	—	$85.27	$83.42	-2.2%	+1.2%	+0.7%	-1.5%	-1.3%	-2.8%
Jan 8	BWG Global	Upgrade	Negative → Mixed	—	$85.50	$85.23	-0.3%	+1.3%	+0.7%	+1.9%	-0.2%	-2.3%
Jan 7	Baird	Downgrade	Outperform → Neutral	—	$89.08	$86.78	-2.6%	-4.0%	-2.8%	-3.4%	-2.2%	-4.2%
Dec 5	Needham	Maintains	Buy → Buy	—	$88.24	$88.04	-0.2%	+1.7%	-2.3%	-2.9%	-1.2%	+1.3%
Oct 31	Barclays	Maintains	Equal Weight → Equal Weight	—	$82.54	$82.77	+0.3%	-1.0%	-1.7%	-4.7%	-2.8%	-5.0%
Oct 31	Stifel	Maintains	Hold → Hold	—	$82.54	$82.77	+0.3%	-1.0%	-1.7%	-4.7%	-2.8%	-5.0%
Oct 21	BofA Securities	Maintains	Buy → Buy	—	$82.34	$82.92	+0.7%	+2.1%	+1.4%	+3.4%	+0.6%	+6.0%
Sep 22	Piper Sandler	Downgrade	Overweight → Neutral	—	$80.32	$78.46	-2.3%	-4.0%	-2.7%	-3.5%	-4.6%	+1.8%
Aug 29	Needham	Maintains	Buy → Buy	—	$86.29	$85.87	-0.5%	+1.1%	+4.7%	+0.6%	+3.2%	+0.2%
Aug 11	UBS	Maintains	Neutral → Neutral	—	$75.24	$75.44	+0.3%	+1.8%	+3.5%	+10.8%	+11.7%	+12.6%
Aug 8	Barclays	Downgrade	Overweight → Equal Weight	—	$74.39	$74.90	+0.7%	+1.1%	+2.9%	+4.7%	+12.1%	+13.0%
Aug 8	BofA Securities	Maintains	Buy → Buy	—	$74.39	$74.90	+0.7%	+1.1%	+2.9%	+4.7%	+12.1%	+13.0%
Aug 8	Stifel	Downgrade	Buy → Hold	—	$74.39	$74.90	+0.7%	+1.1%	+2.9%	+4.7%	+12.1%	+13.0%
Aug 8	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$74.39	$74.90	+0.7%	+1.1%	+2.9%	+4.7%	+12.1%	+13.0%
Aug 7	Needham	Maintains	Buy → Buy	—	$105.13	$81.50	-22.5%	-29.2%	-28.4%	-27.2%	-25.9%	-20.7%
Jul 28	UBS	Maintains	Neutral → Neutral	—	$106.75	$108.25	+1.4%	-1.0%	-2.3%	-4.2%	-6.6%	-9.0%
Jul 22	Goldman Sachs	Maintains	Sell → Sell	—	$103.64	$103.64	+0.0%	+2.6%	+5.0%	+4.0%	+3.0%	+1.9%
Jun 30	BofA Securities	Maintains	Buy → Buy	—	$103.02	$103.75	+0.7%	-1.7%	+4.0%	+3.6%	+4.2%	+3.2%
May 9	Barclays	Maintains	Overweight → Overweight	—	$110.65	$109.47	-1.1%	-0.8%	+7.4%	+8.7%	+6.9%	+6.0%
May 8	Needham	Maintains	Buy → Buy	—	$100.76	$107.30	+6.5%	+9.8%	+8.9%	+18.0%	+19.4%	+17.4%
May 1	Needham	Maintains	Buy → Buy	—	$96.42	$96.51	+0.1%	-1.8%	+1.1%	+4.5%	+2.4%	+4.5%
Apr 11	Piper Sandler	Maintains	Overweight → Overweight	—	$95.50	$93.54	-2.1%	-3.1%	-4.9%	-5.8%	-7.2%	-5.0%
Apr 10	Stifel	Maintains	Buy → Buy	—	$99.59	$96.61	-3.0%	-4.1%	-7.1%	-8.8%	-9.7%	-11.0%
Apr 1	Loop Capital	Maintains	Buy → Buy	—	$106.20	$106.40	+0.2%	+2.8%	+5.0%	-9.6%	-5.2%	-9.8%
Mar 12	Loop Capital	Upgrade	Hold → Buy	—	$98.32	$101.82	+3.6%	+3.6%	+1.7%	+0.3%	+5.6%	+5.3%
Feb 19	UBS	Maintains	Neutral → Neutral	—	$107.35	$107.00	-0.3%	+3.4%	+1.4%	+0.2%	-1.2%	-3.9%
Feb 14	Barclays	Maintains	Overweight → Overweight	—	$110.05	$109.65	-0.4%	-1.5%	-2.5%	+0.8%	-1.1%	-2.2%
Feb 14	BofA Securities	Maintains	Buy → Buy	—	$110.05	$109.65	-0.4%	-1.5%	-2.5%	+0.8%	-1.1%	-2.2%
Feb 13	Needham	Maintains	Buy → Buy	—	$88.83	$110.65	+24.6%	+23.9%	+22.1%	+20.8%	+24.9%	+22.6%
Feb 10	Baird	Maintains	Outperform → Outperform	—	$93.37	$94.31	+1.0%	-2.8%	-4.7%	-4.9%	+17.9%	+16.1%
Feb 3	Guggenheim	Maintains	Buy → Buy	—	$102.07	$98.86	-3.1%	-5.2%	-4.7%	-5.0%	-6.4%	-8.5%
Jan 23	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$102.64	$102.21	-0.4%	+2.4%	+0.9%	-0.2%	+0.9%	+2.1%
Jan 6	BofA Securities	Maintains	Buy → Buy	—	$110.80	$112.80	+1.8%	+1.1%	+0.2%	-1.0%	-0.7%	-4.5%
Dec 6	Guggenheim	Maintains	Buy → Buy	—	$109.91	$111.77	+1.7%	-0.1%	+0.6%	+1.4%	+3.1%	+2.8%
Nov 7	Loop Capital	Downgrade	Buy → Hold	—	$102.74	$102.50	-0.2%	-0.9%	-1.4%	+0.1%	-0.7%	-3.7%
Oct 30	Loop Capital	Maintains	Buy → Buy	—	$111.58	$110.15	-1.3%	-2.3%	-3.4%	-4.8%	-4.7%	-5.7%
Oct 30	Guggenheim	Maintains	Buy → Buy	—	$111.58	$110.15	-1.3%	-2.3%	-3.4%	-4.8%	-4.7%	-5.7%
Oct 30	UBS	Maintains	Neutral → Neutral	—	$111.58	$110.15	-1.3%	-2.3%	-3.4%	-4.8%	-4.7%	-5.7%
Oct 30	Baird	Maintains	Outperform → Outperform	—	$111.58	$110.15	-1.3%	-2.3%	-3.4%	-4.8%	-4.7%	-5.7%
Oct 30	Raymond James	Downgrade	Outperform → Market Perform	—	$111.58	$110.15	-1.3%	-2.3%	-3.4%	-4.8%	-4.7%	-5.7%
Oct 30	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$111.58	$110.15	-1.3%	-2.3%	-3.4%	-4.8%	-4.7%	-5.7%
Oct 29	Barclays	Maintains	Overweight → Overweight	—	$138.05	$113.75	-17.6%	-19.2%	-21.0%	-21.9%	-23.1%	-23.0%

Recent Filings

8-K

Crocs, Inc. -- 8-K Filing

Crocs exceeded Q1 2026 expectations driven by strong consumer demand across both its brand portfolio and strategic execution, signaling positive momentum for the footwear company.

Apr 30

8-K

Crocs, Inc. -- 8-K Filing

Crocs delivered stronger-than-expected fourth quarter 2025 results, demonstrating resilience in its casual footwear business during the critical holiday season.

Feb 12

Data updated apr 25, 2026 3:20am · Source: massive.com